Exact Sciences Corp.(NYSE:EXAS) on Thursday reported a first-quarter 2025 EPS loss of 21 cents, down from a 37-cent loss a year ago, beating the analyst consensus loss estimate of 38 cents.
The company reported quarterly sales of $706.78 million, up 11% year over year on a reported and…